NFL
Asset Logo

Norfolk Metals Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

โ›๏ธ MINING

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-19.38%
Annual Growth

3 years average annual growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

1
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Norfolk Metals Ltd. provides exploration services. The firm is a gold and uranium focused explorer with assets located in Tasmania and South Australia respectively. The company holds interest in Roger River Project and the Orroroo Uranium Project. The Roger River Project comprises two granted exploration licenses, EL20/2020, and EL17/2021, which together cover 261 kilometers (km2), located 410 kilometers (km) northwest of the capital city of Hobart, Tasmania. The Project is prospective for gold and copper as indicated by the intense silicification, argillisation and diatreme breccias in close proximity to the Roger River Fault along with carbonate-rich host rocks. The Orroroo Uranium Project comprises two granted exploration licenses, EL6552, and EL6814, which together cover 659km2, located approximately 274 km northwest of the capital city of Adelaide, South Australia within the Walloway Basin.

๐Ÿ“ˆ Performance

Price History

-52.00%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.10

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in NFL

1

๐Ÿ“Š Total Capital Earnings

$4K

๐Ÿ”ƒ Average investment frequency

9 weeks

๐Ÿ’ต Average investment amount

$1,414

โฐ Last time a customer invested in NFL

90 days
NFL investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

100%
๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

100%
๐Ÿ™‹ Legal gender of investors

Female

Male

100%

Pearlers who invest in NFL also invest in...

Core Lithium Ltd

CXO

Core Lithium Ltd. is an Australian based mineral exploration company, which engages in the acquisition, exploration, evaluation, and development of copper, gold, uranium, and iron ore properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2011-02-11. The company owns and operates Finniss Lithium project, which is located south of Darwin Port in the Northern Territory. The project lies within a prospective area for lithium in the NT, the Bynoe Pegmatite Field, and covers approximately 500 square kilometers (km2) of granted tenements. The project is approximately 88 kilometers (km) by sealed road from Darwin Port, Northern Territory. Its other projects include Shoobridge Lithium, Anningie and Barrow Creek Lithium, Napperby Uranium, Yerelina and Mt Freeling, and Blueys-Inkheart. The Shoobridge Lithium Project is located approximately 80 km south-southeast of Finniss near Darwin in the Northern Territory. The Anningie and Barrow Creek encompass eight exploration licenses over approximately 2,000 km2 in and around the Anningie and Barrow Creek tin-tantalum pegmatite fields in the Northern Territory. Napperby is an advanced uranium project within the central Northern Territory.

๐Ÿ™Œ Performance (5Yr p.a)

28.42%

๐Ÿ“Š Share price

$0.09 AUD

โ›๏ธ MINING

๐Ÿ“ˆ HIGH PRICE GROWTH

Find Out More

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

๐Ÿ™Œ Performance (5Yr p.a)

25.47%

๐Ÿ“Š Share price

$47.72 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿค– TECHNOLOGY

HACK.AX was created on 2016-08-30 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The fund aims to track the performance of an index (before fees and expenses) that provides exposure to the leading companies in the global cybersecurity sector.

๐Ÿ™Œ Performance (5Yr p.a)

14.85%

๐Ÿ“Š Share price

$13.33 AUD

๐Ÿค– TECHNOLOGY

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡ฆ๐Ÿ‡บ EX AUSTRALIA

VEU.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard All-World ex-US Shares Index ETF seeks to track the return of the FTSE All-World ex US Index before taking into account fees, expenses and tax

๐Ÿ™Œ Performance (5Yr p.a)

3.48%

๐Ÿ“Š Share price

$90.88 AUD

โ›ณ๏ธ DIVERSIFIED

๐ŸŒ GLOBAL

RBTZ.AX was created on 2018-09-12 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. RBTZ.AX aims to track the performance of an index (before fees and expenses) that includes global companies involved in the production or use of robotics and artificial intelligence (A.l.) products and services.

๐Ÿ™Œ Performance (5Yr p.a)

8.53%

๐Ÿ“Š Share price

$14.72 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿค– TECHNOLOGY

Want more shares? Try these...

๐Ÿ“Š Share price

$0.04 AUD

๐Ÿ™Œ Performance (5Yr p.a)

0.92%

๐Ÿ“Š Share price

$91.40 AUD

๐Ÿ’ฐ HIGH DIVIDEND

NetLinkz Ltd. provides a flexible, efficient, secure and cost-effective Software-Defined Wide Area Network solution connecting any site to any device, anywhere, on any network with ease. The firm delivers a cloud-based cyber-secure invisible network-as-a-service (NaaS) for enterprise customers. The company is also a global reseller for Starlink satellite Internet services. Its NaaS proposition is user-centric, creating a per-user private network that is available, secure and performance optimized, for authorized users regardless of their location. The company offers a range of products across three categories: Secure Internet, with Netlinkz transforming Starlink technology into a business grade service providing secure Internet and an invisible cloud network; Network Security, which future proofs clientsโ€™ business with Netlinkzโ€™s cloud first private work solutions, and Secure CCTV and IoT, with Netlinkz ensuring that all clientsโ€™ video feeds and data from their CCTV and IoT systems are transferred, integrity checked and securely stored. Its products include Starlink FIXED, Starlink FREEDOM and Starlink MARITIME.

๐Ÿ™Œ Performance (5Yr p.a)

-19.63%

๐Ÿ“Š Share price

$0.00 AUD

๐Ÿค– TECHNOLOGY

Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. The company is headquartered in Melbourne, Victoria. The company went IPO on 2005-02-03. The firm is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Companyโ€™s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The firm has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.

๐Ÿ™Œ Performance (5Yr p.a)

75.50%

๐Ÿ“Š Share price

$12.32 AUD

๐Ÿ“ฆ LOGISTICS

Compare
Add to watchlist